Shalby Ltd — earnings calls

Shalby reported consolidated revenue of Rs 338.6 crore for Q1 FY27, up 11.6% year-on-year, with EBITDA of Rs 49 crore and PAT of Rs 10.5 crore. Management said the Gurgaon international hospital unit achieved EBITDA break-even for the first time since acquisition, while the standalone hospital EBITDA margin declined to 18.4% from 21.6% a year earlier. The MedTech business posted consolidated revenue growth of 53% year-on-year and reported its fourth consecutive quarter of positive EBITDA at the consolidated level.

Shalby reported consolidated Q4 FY26 revenue of Rs 295.5 crore, up 9.4% year-on-year, with EBITDA rising 43.1% to Rs 37.4 crore and EBITDA margin expanding to 12.7%. Consolidated PAT for the quarter stood at Rs 18.5 crore against a loss in the same period last year, aided by a lower tax regime. Management also discussed the Shalby MedTech implant business, which posted its second consecutive quarter of positive EBITDA, and addressed the impact of the U.S.-Iran conflict on the Gurugram international hospital business.